Page 1

CSL Limited 45 Poplar Road Parkville Victoria 3052 Australia CSL ● T +613 9389 1911 F +613 9389 1434 www.csl.com.au ASX Announcement For immediate release 18 February 2021 CSL Delivers a Strong Half Year Result of $ 1.8 Billion¹ Net Profit CSL delivered a strong first half result for 2021 with reported net profit after tax of $ 1,810 million , up 44 % at CC² reflecting : Solid growth in our core immunoglobulin portfolio led by HIZENTRAⓇ Successful transition to own distribution model in China Strong growth in the leading HAE product HAEGARDAⓇ Exceptionally strong performance by Seqirus CSL's diversified portfolio and resilient business model in the midst of COVID - 19 pandemic Full financial recognition of contracted income for UQ COVID - 19 vaccine in first half , after program termination Earnings per share $ 3.98 , up 44 % at CC² Interim dividend³ of US $ 1.04 per share , up 9 % Converted to Australian currency , the interim dividend is approximately A $ 1.34 per share down 9 % FY21 net profit after tax is anticipated to be in the range of approximately $ 2,170 million to $ 2,265 million at constant currency CSL Limited ABN 99 051 588 348 CSL Limited ( ASX : CSL ; USOTC : CSLLY ) today announces a reported net profit after tax of $ 1,810 million for the six months ended 31 December 2020. This result is an increase of 45 % ( or 44 % on a constant currency basis² ) compared to the previous corresponding period . 1 All figures are expressed in US dollars unless otherwise stated . 2 Constant currency ( CC ) removes the impact of exchange rate movements , facilitating comparability of operational performance . For further detail please refer to CSL's Financial Statements for the Half Year ended December 2020 ( Directors ' Report ) . 3 For shareholders with an Australian registered address , the interim dividend of US $ 1.04 per share ( approximately A $ 1.34 ) will be unfranked for Australian tax purposes and paid on 1 April 2021. For shareholders with a New Zealand registered address , the interim dividend of US $ 1.04 per share ( approximately NZ $ 1.44 ) will be paid on 1 April 2021. The exchange rates will be fixed at the record date of 5 March 2021. All other shareholders will be paid in US $ . CSL also offers shareholders the opportunity to receive dividend payments in US $ by direct credit to a US bank account .